High Outlier
Strength
.2 mg/1
Manufacturer
Astellas Pharma US, Inc.NDC
00469123050
Classification
Brand
Dosage Form
GRANULE, FOR SUSPENSION
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
TACROLIMUSApproval Type
New Drug (NDA)
FDA Application
NDA210115On Market Since
5/24/2018
Pharmacological Classes
Calcineurin Inhibitor Immunosuppressant
Calcineurin Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
ASTAGRAF XL 0.5 MG CAPSULE
Brand
00469064773•Astellas Pharma US, Inc.
$2.7786
per EA
NEORAL 25 MG GELATIN CAPSULE
Brand
00078024615•Novartis Pharmaceuticals Corporation
$2.8879
per EA
SANDIMMUNE 25 MG CAPSULE
Brand
00078024015•Novartis Pharmaceuticals Corporation
$4.3773
per EA
ASTAGRAF XL 1 MG CAPSULE
Brand
00469067773•Astellas Pharma US, Inc.
$5.6595
per EA
RESTASIS 0.05% EYE EMULSION
Brand
00023916330•Allergan, Inc.
$10.3144
per EA
RESTASIS 0.05% EYE EMULSION
Brand
00023916360•Allergan, Inc.
$10.3190
per EA
CEQUA 0.09% SOLUTION
Brand
47335050696•Sun Pharmaceutical Industries Inc.
$10.3832
per EA
NEORAL 100 MG GELATIN CAPSULE
Brand
00078024815•Novartis Pharmaceuticals Corporation
$11.5421
per EA
SANDIMMUNE 100 MG CAPSULE
Brand
00078024115•Novartis Pharmaceuticals Corporation
$15.3370
per EA
ASTAGRAF XL 5 MG CAPSULE
Brand
00469068773•Astellas Pharma US, Inc.
$27.7722
per EA